CY 3018
Alternative Names: CY-3018Latest Information Update: 04 Aug 2023
Price :
$50 *
At a glance
- Originator Cyclerion Therapeutics
- Class
- Mechanism of Action Soluble guanylyl cyclase agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical CNS disorders